Acuta Capital Partners as of Sept. 30, 2019
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 31 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kadmon Hldgs | 11.7 | $16M | 6.4M | 2.52 | |
| Iovance Biotherapeutics (IOVA) | 9.6 | $13M | 728k | 18.20 | |
| Arvinas Ord (ARVN) | 8.8 | $12M | 567k | 21.55 | |
| Spdr Series Trust S&p Biotech Put Option (XBI) | 8.3 | $11M | 150k | 76.25 | |
| Arrowhead Pharmaceuticals (ARWR) | 7.9 | $11M | 388k | 28.18 | |
| Axsome Therapeutics (AXSM) | 7.6 | $11M | 523k | 20.24 | |
| Milestone Pharmaceuticals (MIST) | 5.0 | $6.9M | 370k | 18.65 | |
| Xenon Pharmaceuticals (XENE) | 4.6 | $6.3M | 703k | 9.01 | |
| Crispr Therapeutics Namen Akt (CRSP) | 4.0 | $5.5M | 134k | 40.99 | |
| Protagonist Therapeutics (PTGX) | 3.6 | $5.0M | 419k | 12.01 | |
| Bellus Health Com New | 3.6 | $5.0M | 785k | 6.39 | |
| Aurinia Pharmaceuticals (AUPH) | 3.3 | $4.5M | 850k | 5.34 | |
| Insmed Com Par $.01 (INSM) | 2.8 | $3.9M | 220k | 17.64 | |
| Reata Pharmaceuticals Cl A | 2.6 | $3.6M | 45k | 80.29 | |
| Veracyte (VCYT) | 1.9 | $2.7M | 113k | 24.00 | |
| Argenx Se Sponsored Adr (ARGX) | 1.9 | $2.6M | 23k | 113.96 | |
| Karyopharm Therapeutics (KPTI) | 1.6 | $2.3M | 238k | 9.62 | |
| IRIDEX Corporation (IRIX) | 1.6 | $2.2M | 1.2M | 1.85 | |
| Amarin Corp Spons Adr New (AMRN) | 1.1 | $1.5M | 100k | 15.16 | |
| Kura Oncology (KURA) | 1.0 | $1.4M | 95k | 15.17 | |
| Mirati Therapeutics | 1.0 | $1.3M | 17k | 77.88 | |
| Zymeworks | 0.9 | $1.3M | 53k | 24.80 | |
| Ra Pharmaceuticals | 0.9 | $1.3M | 55k | 23.65 | |
| Assembly Biosciences | 0.9 | $1.3M | 132k | 9.83 | |
| Merus N V (MRUS) | 0.9 | $1.2M | 69k | 17.81 | |
| Ptc Therapeutics I (PTCT) | 0.9 | $1.2M | 36k | 33.83 | |
| Amicus Therapeutics (FOLD) | 0.8 | $1.1M | 140k | 8.02 | |
| Applied Therapeutics (APLT) | 0.7 | $912k | 83k | 10.99 | |
| Kalvista Pharmaceuticals (KALV) | 0.2 | $290k | 25k | 11.60 | |
| Sunesis Pharmaceuticals Inc Ne | 0.2 | $288k | 400k | 0.72 | |
| Chembio Diagnostics Com New | 0.2 | $255k | 42k | 6.12 |
